1. Home
  2. BRTX vs VIVS Comparison

BRTX vs VIVS Comparison

Compare BRTX & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$2.31

Market Cap

3.7M

Sector

Health Care

ML Signal

HOLD

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

HOLD

Current Price

$0.20

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRTX
VIVS
Founded
1997
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7M
3.8M
IPO Year
2015
2010

Fundamental Metrics

Financial Performance
Metric
BRTX
VIVS
Price
$2.31
$0.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
169.5K
★ 549.8K
Earning Date
05-13-2026
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
$81,000.00
★ $4,603,000.00
Revenue This Year
$298.39
$42.38
Revenue Next Year
$64.62
$15.42
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 8.82
52 Week Low
$0.14
$0.21
52 Week High
$4.10
$3.54

Technical Indicators

Market Signals
Indicator
BRTX
VIVS
Relative Strength Index (RSI) 56.12 27.63
Support Level $0.22 N/A
Resistance Level $2.93 $0.30
Average True Range (ATR) 0.17 0.02
MACD -0.08 0.00
Stochastic Oscillator 2.35 1.89

Price Performance

Historical Comparison
BRTX
VIVS

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.

Share on Social Networks: